Investing.com - HCA (NYSE: HCA) reported first quarter EPS of $4.85, $0.92 better than the analyst estimate of $3.93. Revenue for the quarter came in at $15.59B versus the consensus estimate of $15.27B.
Guidance
HCA sees FY 2023 EPS of $17.25-$18.55 versus the analyst consensus of $17.25.
HCA sees FY 2023 revenue of $62.50B-$64.50B versus the analyst consensus of $62.60B.
HCA's stock price closed at $270.78. It is up 0% in the last 3 months and up 28.55% in the last 12 months.
HCA saw 0 positive EPS revisions and 14 negative EPS revisions in the last 90 days. See HCA's stock price’s past reactions to earnings here.
According to InvestingPro, HCA's Financial Health score is "great performance".
Check out HCA's recent earnings performance, and HCA's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar